Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.

Kosuke Tsutsumi,Norihiro Sato,Reiko Tanabe,Kazuhiro Mizumoto,Katsuya Morimatsu,Tadashi Kayashima,Hayato Fujita,Kenoki Ohuchida,Takao Ohtsuka,Shunichi Takahata,Masafumi Nakamura,Masao Tanaka

Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.

2012

Kosuke Tsutsumi
Norihiro Sato
Reiko Tanabe
Kazuhiro Mizumoto
Katsuya Morimatsu
Tadashi Kayashima
Hayato Fujita
Kenoki Ohuchida
Takao Ohtsuka
Shunichi Takahata
Masafumi Nakamura
Masao Tanaka

Background Identification of prognostic markers would be useful in the clinical management of patients with pancreatic ductal adenocarcinoma (PDAC). The clinical relevance of claudin-4 (CLDN4), recently identified as overexpressed in PDAC, is unknown.

Keywords:

Pathology
General surgery
Medicine
Claudin
Adenocarcinoma
Oncology
pancreatic ductal adenocarcinoma
Internal medicine
Surgical oncology
Clinical significance

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations